Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF (SJNK) Price & Performance

Centene CorpTrade
State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETFTrade

Price performance (Past 24H)

Key statistics

Centene Corp vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? Centene Corp trades at $66.47 (market cap $33.93B), while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.95. The key difference: Centene Corp is trading nearer its 52-week high, State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF nearer its low. Which is the better fit depends on your goals.

CNCSJNK
Market Cap
$33.93B
Sector
HealthSector/Thematic
52-Week High
$68.72$25.63
52-Week Low
$25.21$24.75
Enterprise Value
$26.56B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF

SJNK trades at $24.88, down slightly by 0.12% over the past day. Technical indicators are predominantly bearish, with moving averages signaling a downtrend and oscillators neutral. The ETF continues its regular dividend payments, with recent distributions of $0.14 and $0.15 per share. Recent news highlights mixed sentiment, with some analysts cautioning on high-yield bonds while institutional positions see increases.

The outlook for SJNK is clouded by bearish technicals and cautious analyst sentiment, though steady dividends provide income support. Key risks include interest rate sensitivity and credit spread volatility in the high-yield bond market. Investors should weigh the income generation against potential capital depreciation in a rising rate environment.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF

SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.

Read more on SJNK